Intellia Therapeutics (NTLA) Shares Outstanding (Diluted) (2020 - 2026)

Intellia Therapeutics (NTLA) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Dil.) (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn 255.20 Mn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn 106.00 Mn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn 64.41 Mn
4 Revolution Medicines 43.64 Bn 43.64 Bn - 210.89 Mn
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn 1.51 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn 25.05 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn - 556.90 Mn
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn 138.28 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn 217.35 Mn
10 Intellia Therapeutics 1.67 Bn 1.67 Bn - 133.48 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 133.48 Mn
Mar 31, 2026 118.49 Mn
Dec 31, 2025 108.38 Mn
Sep 30, 2025 110.19 Mn
Jun 30, 2025 103.73 Mn
Mar 31, 2025 103.50 Mn
Dec 31, 2024 98.85 Mn
Sep 30, 2024 101.00 Mn
Jun 30, 2024 96.98 Mn
Mar 31, 2024 95.50 Mn
Dec 31, 2023 88.77 Mn
Sep 30, 2023 88.65 Mn
Jun 30, 2023 88.19 Mn
Mar 31, 2023 87.77 Mn
Dec 31, 2022 76.97 Mn
Sep 30, 2022 76.05 Mn
Jun 30, 2022 75.82 Mn
Mar 31, 2022 74.75 Mn
Dec 31, 2021 70.89 Mn
Sep 30, 2021 73.71 Mn